Skip to content
Search

Latest Stories

Regulators announce new Pharmacy Quality Scheme for 2021/22

Initial details of the new Pharmacy Quality Scheme (PQS) for 2021/22 released on Thursday (August 12) with a focus on priorities supporting recovery from Covid-19.

PSNC, the Department of Health and Social Care (DHSC), and NHS England and NHS Improvement (NHSE&I) have agreed to the arrangements for the 2021/22 scheme.


"The scheme will officially begin on 1st September 2021 with a declaration period in February 2022. As with previous schemes, it has £75m funding available and contractors will be able to claim an Aspiration payment if they wish to, later this year," PSNC said.

"In our negotiations on the scheme, a key win for PSNC was reducing the scope of this year’s PQS so that the estimated contractor costs and time required to complete the criteria will be well below those associated with the original NHS proposal for the scheme."

PSNC hopes that this, along with arguing for more realistic targets across the scheme, will help reduce the impact on contractor workload.

Discussions on PQS formed part of wider negotiations for Year Three of the five-year Community Pharmacy Contractual Framework (CPCF). However, given that the scheme is now due to begin in a matter of weeks, PSNC pressed for the details to be released now to give contractors a head start on preparation.

The announcement outlines what will be included in the PQS this year, noting:

  • Gateway criteria of at least 20 NMS, patient safety and COVID-19 risk management requirements, plus training on LASA errors and sepsis;
  • Identifying people who would benefit from weight management advice and onward referral;
  • Training on health inequalities and producing an action plan to actively promote COVID-19 vaccinations;
  • Training to develop remote consultation skills;
  • Enhancing antimicrobial stewardship using the Target antibiotic checklist;
  • An anticoagulant audit to enhance patient safety;
  • Engagement with PCNs to increase flu vaccination uptake; and
  • Checking inhaler technique (as part of catch-up NMS) and ensuring patients have personalised asthma action plans, as well as encouraging return of unwanted and used inhalers for environmentally safe disposal.

PSNC advised contractors to review this initial information on the PQS and additional guidance and resources which it will be publishing over the next few days, so contractors can begin work to meet the requirements as early as possible.

Eight of the twelve training requirements have been included in previous PQS; if staff have previously completed the training and, where applicable, successfully passed the e-assessment, there is no requirement to complete this again.

Commenting on the announcement, PSNC Director of NHS Services, Alastair Buxton, said: “The Pharmacy Quality Scheme is now a standard fixture in the community pharmacy contract, providing the sector with an excellent opportunity to show our commitment to patients, further develop our clinical practice and be rewarded for providing high quality care.

“However, with Covid-19 still on all our minds, PSNC has negotiated to reduce the scope of the Government’s original proposal to help manage the impact on contractor workload and costs. We also pushed back to ensure targets across the scheme were realistic in the current environment."

“By pushing Government for the release of these details ahead of other Year Three arrangements, we were seeking to give contractors more time to get going with the scheme, but we also hope that news on the rest of the negotiations will be published shortly, once internal Government processes are complete."

More For You

NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less